PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 22 filers reported holding PDS BIOTECHNOLOGY CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151,819 | -9.7% | 30,063 | -10.1% | 0.00% | – |
| Q2 2023 | $168,123 | -39.0% | 33,424 | -25.4% | 0.00% | – |
| Q1 2023 | $275,544 | -24.0% | 44,804 | +63.1% | 0.00% | – |
| Q4 2022 | $362,710 | +312.2% | 27,478 | -7.5% | 0.00% | – |
| Q3 2022 | $88,000 | -60.9% | 29,700 | -51.7% | 0.00% | – |
| Q2 2022 | $225,000 | -38.2% | 61,531 | +4.6% | 0.00% | – |
| Q1 2022 | $364,000 | +970.6% | 58,840 | +1310.4% | 0.00% | – |
| Q4 2021 | $34,000 | +3300.0% | 4,172 | +7093.1% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 58 | -71.7% | 0.00% | – |
| Q2 2021 | $2,000 | – | 205 | +93.4% | 0.00% | – |
| Q1 2021 | $0 | – | 106 | +606.7% | 0.00% | – |
| Q4 2020 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 15 | -94.3% | 0.00% | – |
| Q4 2019 | $1,000 | -50.0% | 265 | -54.4% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 581 | +388.2% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 119 | -21.2% | 0.00% | – |
| Q1 2019 | $1,000 | – | 151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 117,242 | $311,000 | 0.07% |
| Andesa Financial Management Inc. | 16,655 | $44,000 | 0.04% |
| Sofinnova Investments, Inc. | 142,635 | $378,000 | 0.03% |
| INSPIRION WEALTH ADVISORS, LLC | 22,875 | $61,000 | 0.02% |
| REGENTATLANTIC CAPITAL LLC | 15,753 | $42,000 | 0.00% |
| Ellis Investment Partners, LLC | 2,250 | $5,000 | 0.00% |
| tru Independence LLC | 500 | $0 | 0.00% |
| Renaissance Technologies | 120,269 | $319,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 13,281 | $35,000 | 0.00% |
| VANGUARD GROUP INC | 36,206 | $96,000 | 0.00% |